Descriptions

Apoptotic protease-activating factor 1 (Apaf-1) is a key player in the mitochondrial pathway of apoptosis and composed of three main domains: the N-terminal caspase recruitment domain (CARD), the nucleotide-binding and oligomerization domain (NOD), and the C-terminal WD40-repeat domain (two b-propellers, WD1 and WD2). The NOD is subdivided into the NB-ARC domain and the helical domain. Apaf-1 forms fully inhibited conformation in the absence of cytochrome c with ADP bound in the nucleotide binding site. The NB-ARC domain is held in place through interactions with the b-propeller WD1 and with the helical domain of the NOD, respectively. The presence of a gamma-phosphate in the nucleotide binding site leads to the formation of a salt bridge between R265 and ATP, which is a prerequisite for subsequent rotation of the NB-ARC domain. Binding of cytochrome c between the b-propellers causes propeller WD1 to swing out of its resting position, thereby releasing the attachment of the NB-ARC domain to the regulatory domain. Rotation of the NB-ARC domain exposes the contact areas for oligomerization and relocates the CARD. Apoptotic oligomerization of open Apaf-1 monomers arranges the flexibly tethered CARDs in the central hub of the apoptosomal wheel, where they bind procaspase-9 molecules for activation of the death cascade.

Autoinhibitory domains (AIDs)

Target domain

130-376 (NB-ARC domain)

Relief mechanism

Ligand binding, Partner binding

Assay

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q9I9H8

Entry ID Method Resolution Chain Position Source
AF-Q9I9H8-F1 Predicted AlphaFoldDB

No variants for Q9I9H8

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q9I9H8

No associated diseases with Q9I9H8

19 regional properties for Q9I9H8

Type Name Position InterPro Accession
domain CARD domain 1 - 90 IPR001315
repeat WD40 repeat 606 - 645 IPR001680-1
repeat WD40 repeat 648 - 734 IPR001680-2
repeat WD40 repeat 737 - 785 IPR001680-3
repeat WD40 repeat 795 - 827 IPR001680-4
repeat WD40 repeat 830 - 870 IPR001680-5
repeat WD40 repeat 873 - 921 IPR001680-6
repeat WD40 repeat 944 - 994 IPR001680-7
repeat WD40 repeat 997 - 1121 IPR001680-8
repeat WD40 repeat 1124 - 1172 IPR001680-9
repeat WD40 repeat 1176 - 1212 IPR001680-10
repeat WD40 repeat 1215 - 1254 IPR001680-11
domain NB-ARC 136 - 374 IPR002182
conserved_site WD40 repeat, conserved site 674 - 688 IPR019775
repeat G-protein beta WD-40 repeat 899 - 913 IPR020472-1
repeat G-protein beta WD-40 repeat 1023 - 1037 IPR020472-2
repeat G-protein beta WD-40 repeat 1066 - 1080 IPR020472-3
domain APAF-1 helical domain 456 - 589 IPR041452
domain Apoptotic protease-activating factor 1, winged-helix domain 380 - 447 IPR048975

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
apoptosome A multisubunit protein complex involved in the signaling phase of the apoptotic process. In mammals it is typically composed of seven Apaf-1 subunits bound to cytochrome c and caspase-9. A similar complex to promote apoptosis is formed from homologous gene products in other eukaryotic organisms.

2 GO annotations of molecular function

Name Definition
ADP binding Binding to ADP, adenosine 5'-diphosphate.
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.

2 GO annotations of biological process

Name Definition
apoptotic signaling pathway The series of molecular signals which triggers the apoptotic death of a cell. The pathway starts with reception of a signal, and ends when the execution phase of apoptosis is triggered.
regulation of apoptotic process Any process that modulates the occurrence or rate of cell death by apoptotic process.

19 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q3MJ13 WDR72 WD repeat-containing protein 72 Homo sapiens (Human) PR
O14727 APAF1 Apoptotic protease-activating factor 1 Homo sapiens (Human) EV
O88879 Apaf1 Apoptotic protease-activating factor 1 Mus musculus (Mouse) EV
Q9EPV5 Apaf1 Apoptotic protease-activating factor 1 Rattus norvegicus (Rat) SS
O64973 RPS5 Disease resistance protein RPS5 Arabidopsis thaliana (Mouse-ear cress) PR
P60838 SUMM2 Disease resistance protein SUMM2 Arabidopsis thaliana (Mouse-ear cress) PR
P0C8S1 RPP8L2 Probable disease resistance RPP8-like protein 2 Arabidopsis thaliana (Mouse-ear cress) PR
Q8W3K3 At1g58400 Putative disease resistance protein At1g58400 Arabidopsis thaliana (Mouse-ear cress) PR
Q9C646 RXW24L Probable disease resistance protein RXW24L Arabidopsis thaliana (Mouse-ear cress) PR
Q9XIF0 At1g59780 Putative disease resistance protein At1g59780 Arabidopsis thaliana (Mouse-ear cress) PR
Q940K0 UNI Disease resistance protein UNI Arabidopsis thaliana (Mouse-ear cress) PR
O22727 At1g61190 Probable disease resistance protein At1g61190 Arabidopsis thaliana (Mouse-ear cress) PR
O64790 At1g61300 Probable disease resistance protein At1g61300 Arabidopsis thaliana (Mouse-ear cress) PR
O64789 At1g61310 Probable disease resistance protein At1g61310 Arabidopsis thaliana (Mouse-ear cress) PR
Q39214 RPM1 Disease resistance protein RPM1 Arabidopsis thaliana (Mouse-ear cress) PR
Q9LRR4 RPPL1 Putative disease resistance RPP13-like protein 1 Arabidopsis thaliana (Mouse-ear cress) PR
Q38834 RPP13L4 Disease resistance RPP13-like protein 4 Arabidopsis thaliana (Mouse-ear cress) PR
Q9T048 At4g27190 Disease resistance protein At4g27190 Arabidopsis thaliana (Mouse-ear cress) PR
Q9FJB5 RPP8L3 Disease resistance RPP8-like protein 3 Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MEERARSRLL RSKATLEQDI KASYLMDHMI SDGVLTNDEE AKVLSKATRK EQAVALLETL
70 80 90 100 110 120
LRKDNRAYIS FYNALIRESY GDLASLLHSD LPLLSPEGEK SFADGVSPSV QAILSVGGVP
130 140 150 160 170 180
QRPVVFVSRP PLLNLIREML YQLRDTPGWV TVFGMAGSGK SVMAAEVVRD RSLIKECFPD
190 200 210 220 230 240
GVHWLSVGQC ERADLLVRMQ SLCFRLEQCQ SSDTSQRPPS TVEEAKERLR FLMLRRFPRS
250 260 270 280 290 300
LLILDDVWDS SSLRSFDIQC RVLLTTRNRA LTDSVSGVRY EVPVENGLDE EKALEILALY
310 320 330 340 350 360
VNGKMHKLPE QARSIVSECK GSPLVVSLIG ALLREFPDRW SYYLRQLQQK QFKRIRKSSS
370 380 390 400 410 420
YDYEALDQAM DASLQVLEAE HQELYRDLSV MQKDIKVPAK VLSVLWGLEL EEVEDVLQEF
430 440 450 460 470 480
VNKSLLFRDC NQRPYRYYLH DLQLDFLAEQ NRDQIAELHK KMVRQYQRFY SKRPPDSADK
490 500 510 520 530 540
DSLYWYQFIP YHMAKAGLSK ELYSLMFSLD WVKEKARIMG SAHLINDYVE YGEILDKENS
550 560 570 580 590 600
EVRVQFQEFL SLNGHHLEQR PFPDVVQLAL SQPDRSEVYR QALMQAQKRA SRGQIYLNWV
610 620 630 640 650 660
NKNIEEGLSR LVMHPHQGAV YYACFSKDGS KIASCGASKA LRVFKSTSGE KLLELQAHEE
670 680 690 700 710 720
DVLCCAFSPD DRHIATCASD RKVKLWNVER GVLIREFEVE HEEQINHCQF TNTGRRVLLA
730 740 750 760 770 780
TCSNDKFTNT RLWNPNKKTS QNTMFGHMEP VNHCCFSPND LYLATSSSDG SLKLFEVSSA
790 800 810 820 830 840
NEWKSIDVDS FFPESDEEIK AMVKCSTWSA DGSQIICAAR NTVFVFDVET SDLLLKLKTS
850 860 870 880 890 900
RLSTIQFCHA CPNSSLLAVA LSHYTVELWN FESSKKKAEC SGHLSWVHCV QFSPDGSLLL
910 920 930 940 950 960
SSSDDQTIRL WETDRVHTSS AVALKRDTDV LSSHSDATII APDSSNRLQV LSGSTGAVVL
970 980 990 1000 1010 1020
ESEELSSRIR CSCISRNAAF VALGSEDGTV QVIEVPSSKA SVKLSGHTKT VHHCQFTDDC
1030 1040 1050 1060 1070 1080
EILITSSEDS TIRVWKWRTG ECMVLQGHME PVRKFHLLSS SSSPHLFSWS FDGTVKVWDL
1090 1100 1110 1120 1130 1140
TRGQMLQDLV CHEGAVLSCD VSSDGRLFAT TSANRTAKVW SSASWKMLFL LEGHKDCVRS
1150 1160 1170 1180 1190 1200
CRFSWDNKRL ATGDDNGEIR LWSMLDGALL KICPRDTKDS MNSYHAGWVT DLHFSPDNRV
1210 1220 1230 1240 1250 1260
LVSTAGYIKW WSVESGEALQ TFYTMGGNLK KIHVSPDFST FITVDSIGIL YILKRLEGEG
T